glp 1 oral dosage for weight loss GLP-1 Therapy Obesity and Type 2 Diabetes New oral GLP-1s are changing

The medication is contraindicated in patients with uncontrolled hypertension, seizure disorders, or current use of MAO inhibitors

Both preclinical and clinical studies suggest that GLP-1 RAs reduce systemic and central inflammation, potentially restoring immune homeostasis in brain regions critical for emotional regulation and reward processing, such as the prefrontal cortex and limbic structures [26,82,84]

Insurance companies usually dont cover semaglutide for weight loss because obesity is still considered a cosmetic issue as opposed to a chronic disease

Dosing accuracy with compounded injectables requires careful adherence to clinician and pharmacy instructions